Showing results (241-250 of 307) with videos related to
Sort By:
Pageof 31
Biochemical Pharmacology|March 10, 2012
Novel fluorescent antagonist as a molecular probe in A(3) adenosine receptor binding assays using flow cytometryEszter Kozma, T Santhosh Kumar, Stephanie Federico, et al.European Journal of Medicinal Chemistry|May 21, 2013
New insight into adenosine receptors selectivity derived from a novel series of [5-substituted-4-phenyl-1,3-thiazol-2-yl] benzamides and furamidesGajanan S Inamdar, Amit N Pandya, Hardik M Thakar, et al.European Journal of Medicinal Chemistry|November 9, 2016
Synthesis, structure-activity relationships and biological evaluation of 7-phenyl-pyrroloquinolinone 3-amide derivatives as potent antimitotic agentsDavide Carta, Roberta Bortolozzi, Mattia Sturlese, et al.Nature Cell Biology|September 28, 2011
USP15 is a deubiquitylating enzyme for receptor-activated SMADsMasafumi Inui, Andrea Manfrin, Anant Mamidi, et al.Journal of Medicinal Chemistry|June 19, 2026
Applying Deep-Learning-Driven De Novo Design to Hit Identification: A Case Study on A2A Adenosine Receptor AntagonistsMargherita Persico, Alessandra Micoli, Veronica Salmaso, et al.Bioorganic & Medicinal Chemistry Letters|October 11, 2017
Sulfonamido-derivatives of unsubstituted carbazoles as BACE1 inhibitorsSimone Bertini, Elisa Ghilardi, Valentina Asso, et al.Biochemical Pharmacology|November 22, 2019
A2A and A2B adenosine receptors: The extracellular loop 2 determines high (A2A) or low affinity (A2B) for adenosineElisabetta De Filippo, Sonja Hinz, Veronica Pellizzari, et al.Journal of Medicinal Chemistry|June 23, 2006
4-amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as new potent and selective human A3 adenosine receptor antagonists. synthesis, pharmacological evaluation, and ligand-receptor modeling studiesOmbretta Lenzi, Vittoria Colotta, Daniela Catarzi, et al.Journal of Medicinal Chemistry|February 8, 2002
Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonistsPier Giovanni Baraldi, Barbara Cacciari, Stefano Moro, et al.Journal of Medicinal Chemistry|September 13, 2013
Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitorsMaria Grazia Ferlin, Davide Carta, Roberta Bortolozzi, et al.Pageof 31